Immunoglobulin News and Research

RSS

Owner SARS-CoV-2 RNA load shown to be associated with infection in pet dogs

A new study assessed the potential association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load in owners with SARS-CoV-2 infection in their dogs.

17 Oct 2022

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

A new review discussed the applications of single-cell ribonucleic acid sequencing (scRNA-seq) in understanding autoimmune disorders.

17 Oct 2022

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Researchers evaluated the changing risk of severe COVID-19 outcomes in individuals with primary and secondary immunodeficiencies in the context of COVID-19 vaccinations.

17 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Chinese study determines the real-world effectiveness of COVID-19 vaccines

A recent study aimed to determine the real-world effectiveness of COVID-19 vaccines against SARS-CoV-2 infection.

14 Oct 2022

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Researchers examined single clones of SARS-CoV-2-specific memory B cells to understand their adaptability and fate.

13 Oct 2022

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

In a new study, researchers investigated the long-term efficacy, safety, and durability of all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines used in Denmark.

13 Oct 2022

Modeling the risk factors for household transmission of SARS-CoV-2

Researchers analyze the risks of contracting SARS-CoV-2 from the household and community

12 Oct 2022

Antibody response trajectories among solid organ transplant recipients in association with mycophenolate mofetil administration

Researchers explored the trajectory of antibody (Ab) titers after coronavirus disease 2019 (COVID-19) vaccination among solid organ transplant recipients (SOTs) with or without mycophenolate mofetil (MMF), or withdrawn from MMF.

11 Oct 2022

The association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case report

The case report of a patient who developed pneumonitis and thrombocytopenia concurrently after being administered the COVID-19 vaccine.

11 Oct 2022

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

In a new study, researchers investigated the breadth and longevity of immunity induced by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among the Kenyan population.

10 Oct 2022

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

A new study demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age.

7 Oct 2022

Spike-specific memory B cells develop resilience to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers explored the cross-reactivity, avidity, and kinetics of memory B-cells and serum antibodies in vaccinated and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals.

4 Oct 2022

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

In a new study, researchers assessed the immunoglobulin (Ig)-G responses to SARS-CoV-2 after natural infection or vaccination.

3 Oct 2022

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

A recent Frontiers in Immunology journal study by University of North Carolina at Chapel Hill and Vanderbilt University researchers has created an in vitro system to determine potential therapeutics targeting sensitized effector cells based on human, allergen-specific, Immunoglobulin E (IgE) monoclonal antibodies (mAbs).

2 Oct 2022

Study reveals immune characteristics of long-COVID

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Researchers explored SARS-CoV-2 variants of concern/interest (VOC/VOI) kinetics and variations among non-hospitalized acute COVID-19 patients.

29 Sep 2022

Immunoglobulin News and Research

Owner SARS-CoV-2 RNA load shown to be associated with infection in pet dogs

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Did the risk of severe COVID-19 in the immunodeficient population of the UK change following vaccination deployment?

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Chinese study determines the real-world effectiveness of COVID-19 vaccines

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

Modeling the risk factors for household transmission of SARS-CoV-2

Antibody response trajectories among solid organ transplant recipients in association with mycophenolate mofetil administration

The association of BNT16B2b2 mRNA COVID-19 vaccine with thrombocytopenia and pneumonitis: A case report

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

Spike-specific memory B cells develop resilience to SARS-CoV-2

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

Study reveals immune characteristics of long-COVID

What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants?

Study suggests B-cell responses to booster vaccines are impeded by recent SARS-CoV-2 infection

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News